Vor Biopharma Analyst Price Targets

Vor Biopharma Inc

VORNASDAQ

$18.33

가까이에: Sep 30, 5:00 PM EST

$18.33

N/A

시간외: 4:00 PM EST

Wall Street analyst price targets and consensus rating for Vor Biopharma (VOR).

Price Target Range — 11 Quarters

Analyst Consensus — 12 Analysts

10Buy

2Hold

Consensus RatingBuy# Analysts12Avg. Consensus PT$62Upside to Avg. PT+236.4%

Rating Trend — Last 9 Months

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 12, 2026	Wedbush	Martin Fan	PT Raise	Neutral	$18→$27
May 18, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$31
May 14, 2026	Wedbush	Martin Fan	PT Raise	Neutral	$15→$18
Apr 15, 2026	HC Wainwright & Co.	Swayampakula Ramakanth	PT Cut	Buy	$32→$31
Mar 31, 2026	Wedbush	Martin Fan	PT Raise	Neutral	$9→$15
Mar 30, 2026	Jefferies	Farzin Haque	Initiate	Buy	$50
Mar 19, 2026	Wells Fargo	Sadia Rahman	Initiate	Overweight	$30
Jan 9, 2026	Citigroup	Geoff Meacham	Initiate	Buy	$50
Dec 19, 2025	JP Morgan	Anupam Rama	PT Cut	Overweight	$43→$40
Dec 17, 2025	TD Cowen	Yaron Werber	Initiate	Buy	—
Dec 9, 2025	JP Morgan	Anupam Rama	Initiate	Overweight	$43
Nov 25, 2025	Wedbush	Martin Fan	Assumes	Neutral	$9
Nov 14, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Cut	Buy	$55→$32
Oct 29, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	PT Raise	Buy	$3→$55
Oct 15, 2025	Baird	Jack Allen	Upgrade	Neutral→Outperform	$20→$64
Aug 14, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Maintained	Buy	$3
Jun 30, 2025	HC Wainwright & Co.	Swayampakula Ramakanth	Upgrade	Neutral→Buy	$3
Jun 27, 2025	Baird	Jack Allen	PT Raise	Neutral	$0→$1
Jun 26, 2025	Wedbush	David Nierengarten	Maintained	Neutral	$0
May 9, 2025	JMP Securities	Silvan Tuerkcan	Downgrade	Market Outperform→Market Perform	$6